Suchergebnisse - "Dodds, Michael"

PubPharm (142)

21

Fluvoxamine for the treatment of COVID-19

enthalten in: The Lancet. Global health | 2022

von Dodds, M. | Doyle, E. | Reiersen, A. | +2

CommentOn: Lancet Glob Health. 2022 Jan;10(1):e42-e51. - PMID 34717820

22

Efectos antibacterianos sinérgicos del extracto de corteza de magnolia y de éster etílico de N-alfa-lauroil-L-arginina sobre biopelícula de placa dental

enthalten in: Europäisches Patentamt | 2022

von DODDS MICHAEL W | TIAN MINMIN | INUI TAICHI | +2

23

COVID‐19 acute respiratory distress syndrome : A simulation study of the effects of combination therapy with tocilizumab and siltuximab

enthalten in: British Journal of Clinical Pharmacology | 2022

von Doyle, E. | Bentley, D. | Dodds, M.

24

Synergistic antibacterial effects of magnolia bark extract and L-arginine, N-alpha-lauroyl ethyl ester on salivary bacteria

enthalten in: Europäisches Patentamt | 2021

von DODDS MICHAEL W | TIAN MINMIN | INUI TAICHI | +1

25

Synergistic antibacterial effects of magnolia bark extract and L-arginine, N-alpha-lauroyl ethyl ester on plaque biofilm

enthalten in: Europäisches Patentamt | 2021

von TIAN MINMIN | DODDS MICHAEL W | INUI TAICHI | +2

26

Synergistic antibacterial effects of magnolia bark extract and L-arginine, N-alpha-lauroyl ethyl ester on plaque biofilm

enthalten in: Europäisches Patentamt | 2021

von TIAN MINMIN | DODDS MICHAEL W | INUI TAICHI | +2

27

Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma

enthalten in: Clinical pharmacokinetics | 2021

von Ogasawara, K. | Dodds, M. | Mack, T. | +3

ErratumIn: Clin Pharmacokinet. 2021 Jul 3;:. - PMID 34216384

28

Correction to : Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma

enthalten in: Clinical pharmacokinetics | 2021

von Ogasawara, K. | Dodds, M. | Mack, T. | +3

ErratumFor: Clin Pharmacokinet. 2021 Dec;60(12):1621-1633. - PMID 34125421

29

Magnolia bark extract as a hydrophobic ligand for preferential removal of gram negative bacteria from the oral cavity

enthalten in: Europäisches Patentamt | 2021

von BUSSCHER HENK J | DODDS MICHAEL W | MAITRA AMARNATH | +2

30

Using in silico viral kinetic models to guide therapeutic strategies during a pandemic : An example in SARS-CoV-2

enthalten in: British journal of clinical pharmacology | 2021

von Patel, K. | Dodds, M. | Gonçalves, A. | +4